These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3360488)

  • 1. Post-dexamethasone plasma cortisol levels in depressive patients receiving electro-convulsive therapy.
    Varma SL; Lal N; Trivedi JK; Anand M
    Indian J Med Res; 1988 Jan; 87():86-91. PubMed ID: 3360488
    [No Abstract]   [Full Text] [Related]  

  • 2. The overnight dexamethasone suppression test: clinical and theoretical review.
    Gwirtsman H; Gerner RH; Sternbach H
    J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to dexamethasone in affective disorder outpatients.
    Steardo L; Cardone G; Casiello M; Sorge F; Muscettola G
    Acta Psychiatr Belg; 1984; 84(3):218-27. PubMed ID: 6485840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECT-responsive nonmelancholic depression associated with extreme concentrations of post-dexamethasone cortisol.
    Fogel BS
    Biol Psychiatry; 1984 Oct; 19(10):1477-80. PubMed ID: 6518203
    [No Abstract]   [Full Text] [Related]  

  • 7. Anxiety/depression: current management and future directions. Biologic markers and treatment response.
    Carroll BJ
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):30-40. PubMed ID: 6348035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation.
    Joffe R; Brown P; Bienenstock A; Mitton J
    Biol Psychiatry; 1984 Mar; 19(3):347-52. PubMed ID: 6426532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol hypersecretion predicts early depressive relapse after recovery with electroconvulsive therapy.
    Cosgriff JP; Abbott RM; Oakley-Browne MA; Joyce PR
    Biol Psychiatry; 1990 Dec; 28(11):1007-10. PubMed ID: 2125840
    [No Abstract]   [Full Text] [Related]  

  • 11. Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonate.
    Jaeckle RS; Dilsaver SC
    Acta Psychiatr Scand; 1986 Jul; 74(1):68-72. PubMed ID: 2876588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of 94 dexamethasone tests in a population of patients manifesting depressive symptomatology within the framework of a manic-depressive psychosis or other psychotic state].
    Terra JL; Patricot MC; Dalery J; Mathian B; Greffe J; Guyotat J
    Encephale; 1985; 11(4):171-4. PubMed ID: 4085403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic functions, sleep and circadian rhythms in affective disorders.
    Mendlewicz J; Linkowski P
    Adv Biochem Psychopharmacol; 1987; 43():221-36. PubMed ID: 3035888
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship of dexamethasone (2 mg) and plasma cortisol hypersecretion in depressive illness: clinical and neuroendocrine parameters.
    Asnis GM; Halbreich U; Sachar EJ; Nathan RS; Davies M; Novacenko H; Ostrow LC; Endicott J; Puig-Antich J
    Psychopharmacol Bull; 1982 Oct; 18(4):122-6. PubMed ID: 7156272
    [No Abstract]   [Full Text] [Related]  

  • 15. Serial dexamethasone suppression tests among rapidly cycling bipolar patients.
    Greden JF; DeVigne JP; Albala AA; Tarika J; Buttenheim M; Eiser A; Carroll BJ
    Biol Psychiatry; 1982 Apr; 17(4):455-62. PubMed ID: 7082711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dexamethasone test in the diagnosis and treatment of affective psychoses].
    Evsegneev RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):98-101. PubMed ID: 2750393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients.
    Vukadin M; Birkenhäger TK; Wierdsma AI; Groenland TH; van den Broek WW
    J Psychiatr Res; 2011 Sep; 45(9):1165-9. PubMed ID: 21481419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference by carbamazepine with the dexamethasone suppression test.
    Privitera MR; Greden JF; Gardner RW; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1982 May; 17(5):611-20. PubMed ID: 7093397
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma corticosterone in dexamethasone suppression test on depressed patients.
    Li SW; Ritchie JC; Carroll BJ
    Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(2):72-9. PubMed ID: 2798403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
    Lee MA; Taylor MA
    Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.